Cerebrospinal Fluid Neurone-Specific Enolase in Mitochondrial Encephalomyopathies
- 46 Downloads
Whether cerebrospinal fluid (CSF) neurone-specific enolase (NSE) contributes to the diagnosis of mitochondrial encephalomyopathies (MEMs) is unknown. Aim of the present study was thus to assess the validity of CSF-NSE in the diagnosis of MEM. CSF-NSE was determined in 24 controls, aged 28–88 years; and 23 MEM patients, aged 47–81 years. In controls, CSF-NSE was independent of sex (p = 0.849) and age (p = 0.346). Twenty-one MEM patients had clinical CNS involvement and two CNS abnormalities on imaging investigations exclusively. CSF cells were increased in 7, CSF protein in 17, CSF glucose in 1, and CSF lactate in 2 MEM patients. The upper reference limit of CSF-NSE was 14.66 ng/mL. CSF-NSE was elevated in 6 (26%) MEM patients. CSF-NSE was increased in a single MEM patient with subclinical CNS involvement. This study shows that CSF-NSE is elevated in only one quarter of the MEM patients. Determination of CSF-NSE appears to be of minor importance for the assessment of clinical or subclinical CNS involvement in MEM.
KeywordsGlycolysis neuronal and glial damage lumbar puncture mitochondriopathy respiratory chain
Unable to display preview. Download preview PDF.
- Beaudry, P., Cohen, P., Brandel, J.P., Delasnerie-Laupretre, N., Richard, S., Launay, J.M., and Laplanche, J.L. (1999). 14-3-3 Protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement. Geriatr. Cogn. Disord. 10:40–46.CrossRefPubMedGoogle Scholar
- Brockmann, K., Bjornstad, A., Dechent, P., Korenke, C.G., Smeitink, J., Trijbels, J.M., Athanassopoulos, S., Villagran, R., Skjeldal, O.H., Wilichowski, E., Frahm, J., and Hanefeld, F. (2002). Succinate in dystrophic white matter: A proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann. Neurol. 52:38–46.CrossRefPubMedGoogle Scholar
- Osterlundh, G., Bjure, J., Lannering, B., Kjellmer, I., Uvebrant, P., and Marky, I. (1999). Regional cerebral blood flow and neuron-specific enolase in cerebrospinal fluid in children with acute lymphoblastic leukemia during induction treatment. J. Pediatr. Hematol. Oncol. 21:378–383.CrossRefPubMedGoogle Scholar
- Pleines, U.E., Morganti-Kossmann, M.C., Rancan, M., Joller, H., Trentz, O., and Kossmann, T. (2001). S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J. Neurotrauma 18:491–498.CrossRefPubMedGoogle Scholar
- Steinhoff, B.J., Tumani, H., Otto, M., Mursch, K., Wiltfang, J., Herrendorf, G., Bittermann, H.J., Felgenhauer, K., Paulus, W., and Markakis, E. (1999). Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy. Epilepsy Res. 36:75–82.CrossRefPubMedGoogle Scholar
- Studahl, M., Rosengren, L., Gunther, G., and Hagberg, L. (2000). Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J. Neurol. 247:636–642.CrossRefPubMedGoogle Scholar
- Younes-Mhenni, S., Thobois, S., Streichenberger, N., Giraud, P., Mousson-de-Camaret, B., Montelescaut, M.E., Broussolle, E., and Chazot, G. (2002). Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications. Rev. Med. Int. 23:1027–1029.Google Scholar